Optimized Extraction of Amikacin from Murine Whole Blood.
pharmaco-toxicological investigation
sample derivatization
screening of extraction conditions
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
27 Jan 2021
27 Jan 2021
Historique:
received:
11
01
2021
revised:
25
01
2021
accepted:
26
01
2021
entrez:
30
1
2021
pubmed:
31
1
2021
medline:
16
4
2021
Statut:
epublish
Résumé
Amikacin (Amk) analysis and quantitation, for pharmacokinetics studies and other types of investigations, is conventionally performed after extraction from plasma. No report exists so far regarding drug extraction from whole blood (WB). This can represent an issue since quantification in plasma does not account for drug partitioning to the blood cell compartment, significantly underrating the drug fraction reaching the blood circulation. In the present work, the optimization of an extraction method of Amk from murine WB has been described. The extraction yield was measured by RP-HPLC-UV after derivatization with 1-fluoro-2,4-dinitrobenzene, which produced an appreciably stable derivative with a favorable UV/vis absorption. Several extraction conditions were tested: spiked Amk disulfate solution/acetonitrile/WB ratio; presence of organic acids and/or ammonium hydroxide and/or ammonium acetate in the extraction mixture; re-dissolution of the supernatant in water after a drying process under vacuum; treatment of the supernatant with a solution of inorganic salts. The use of 5% (by volume) of ammonium hydroxide in a hydro-organic solution with acetonitrile, allowed the almost quantitative (95%) extraction of the drug from WB.
Identifiants
pubmed: 33513993
pii: molecules26030665
doi: 10.3390/molecules26030665
pmc: PMC7865403
pii:
doi:
Substances chimiques
Acetonitriles
0
Ammonium Hydroxide
5138Q19F1X
Amikacin
84319SGC3C
acetonitrile
Z072SB282N
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Drugs R D. 2017 Mar;17(1):177-187
pubmed: 28063020
Talanta. 2016 Apr 1;150:510-5
pubmed: 26838437
Crit Care Clin. 2011 Jan;27(1):107-21
pubmed: 21144989
Clin Pharmacol Ther. 1974 Jun;15(6):610-6
pubmed: 4210297
J Pharm Biomed Anal. 2015 Dec 10;116:40-6
pubmed: 25617178
J Clin Pharmacol. 1991 Feb;31(2):158-63
pubmed: 2010561
ASAIO J. 2018 Sep/Oct;64(5):686-688
pubmed: 29045281
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6540-6549
pubmed: 27550345
AAPS PharmSciTech. 2013 Jun;14(2):828-37
pubmed: 23620260
Drugs. 2019 Apr;79(5):555-562
pubmed: 30877642
Crit Care Med. 2019 Jun;47(6):e470-e477
pubmed: 30882478
J Pharm Biomed Anal. 2020 Feb 20;180:113066
pubmed: 31891875
Infect Drug Resist. 2018 Feb 13;11:223-228
pubmed: 29483780
J Antimicrob Chemother. 1999 Aug;44(2):235-42
pubmed: 10473231
J Chromatogr. 1992 Feb 7;574(1):93-9
pubmed: 1629293
Cold Spring Harb Perspect Med. 2016 Jun 01;6(6):
pubmed: 27252397
Molecules. 2017 Dec 19;22(12):
pubmed: 29257114
J Infect Dis. 1976 Nov;134 SUPPL:S316-22
pubmed: 825589
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28115351
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30082284
Pharmaceutics. 2021 Jan 10;13(1):
pubmed: 33435166
J Antimicrob Chemother. 1991 May;27 Suppl C:29-40
pubmed: 1830302